Eargo Inc Quick Ratio (EAR) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Eargo Inc   (NASDAQ: EAR)

Eargo Inc 's Quick Ratio

EAR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 2.62 below Eargo Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 82 other companies have achieved higher Quick Ratio than Eargo Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 708 to 1277.

Explain Quick Ratio?
How much Cash & cash equivalents EAR´s has?
What are EAR´s Current Liabilities?




EAR Quick Ratio (Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
Y / Y Current Liabilities Change -87.37 % -83.91 % -65.4 % -62.4 % 96.14 %
Y / Y Cash & cash equivalent Change -47.75 % -43 % -10.6 % -8.38 % -43.7 %
Quick Ratio MRQ 2.62 2.96 3.19 4.01 0.63
EAR's Total Ranking # 1277 # 708 # 957 # 694 # 2517
Seq. Current Liabilities Change -14.27 % -17.92 % -0.98 % -81.87 % 9.21 %
Seq. Cash & cash equivalent Change -24.28 % -23.81 % -21.2 % 14.95 % -17.4 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 83
Healthcare Sector # 569
Overall Market # 1277


Quick Ratio Statistics
High Average Low
8.95 3.46 0.6
(Dec 31 2020)   (Sep 30 2022)




Financial Statements
Eargo Inc 's Current Liabilities $ 18 Millions Visit EAR's Balance sheet
Eargo Inc 's Cash & cash equivalent $ 46 Millions Visit EAR's Balance sheet
Source of EAR's Sales Visit EAR's Sales by Geography


Cumulative Eargo Inc 's Quick Ratio

EAR's Quick Ratio for the trailling 12 Months

EAR Quick Ratio

(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -78.24 % -37.85 % 41.54 % 118.79 % 264.18 %
Y / Y Cash & cash equivalent TTM Growth -27.03 % -28.72 % -29.84 % -40.55 % -47.38 %
Quick Ratio TTM 3.26 1.57 1.19 1.06 0.97
Total Ranking TTM # 4081 # 3715 # 812 # 2973 # 1862
Seq. Current Liabilities TTM Growth -57.93 % -33.75 % -12.97 % -10.32 % 20.2 %
Seq. Cash & cash equivalent TTM Growth -12.75 % -12.2 % -2.45 % -2.35 % -14.77 %


On the trailing twelve months basis Current Liabilities decreased faster than Eargo Inc 's average Cash & cash equivalent, this led to increase in in Eargo Inc 's Quick Ratio to 3.26, above EAR average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 216 other companies have achieved higher Quick Ratio than Eargo Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3715 to 4081.

Explain Quick Ratio?
How much Cash & cash equivalents EAR´s has?
What are EAR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 217
Healthcare Sector # 1077
Within the Market # 4081


trailing twelve months Quick Ratio Statistics
High Average Low
7.22 2.91 0.92
(Jun 30 2021)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Stereotaxis Inc   7.07 $ 45.550  Millions$ 6.446  Millions
Akili Inc   7.03 $ 86.281  Millions$ 12.275  Millions
Rxsight Inc   6.96 $ 131.882  Millions$ 18.942  Millions
Procept Biorobotics Corporation  6.94 $ 287.087  Millions$ 41.356  Millions
Sharps Technology Inc   6.68 $ 6.028  Millions$ 0.902  Millions
Envveno Medical Corporation  6.65 $ 25.697  Millions$ 3.865  Millions
Aethlon Medical Inc   5.95 $ 10.176  Millions$ 1.711  Millions
Tandem Diabetes Care Inc   5.94 $ 498.158  Millions$ 83.899  Millions
Iradimed Corporation  5.93 $ 46.745  Millions$ 7.882  Millions
Lyra Therapeutics Inc   5.86 $ 102.550  Millions$ 17.509  Millions
Orasure Technologies Inc  5.49 $ 224.891  Millions$ 40.947  Millions
Dariohealth Corp   5.46 $ 44.273  Millions$ 8.106  Millions
Inari Medical Inc   5.32 $ 351.295  Millions$ 66.066  Millions
Orchestra Biomed Holdings Inc   5.25 $ 108.850  Millions$ 20.726  Millions
Valion Bio Inc   5.17 $ 5.169  Millions$ 1.000  Millions
Femasys Inc   5.10 $ 8.692  Millions$ 1.705  Millions
Avita Medical Inc   5.09 $ 60.269  Millions$ 11.836  Millions
Glucotrack Inc   4.74 $ 6.888  Millions$ 1.454  Millions
Pulmonx Corporation  4.63 $ 94.945  Millions$ 20.485  Millions
Solana Company  4.60 $ 6.596  Millions$ 1.435  Millions
Glaukos Corp  4.48 $ 300.857  Millions$ 67.147  Millions
Skinhealth Systems Inc   4.44 $ 559.444  Millions$ 125.879  Millions
Clearpoint Neuro Inc   4.36 $ 24.342  Millions$ 5.589  Millions
Profound Medical Corp   4.12 $ 26.213  Millions$ 6.366  Millions
Dror Ortho-Design, Inc.  4.09 $ 4.016  Millions$ 0.981  Millions
Bone Biologics Corporation  4.04 $ 4.453  Millions$ 1.103  Millions
Sensus Healthcare Inc   3.92 $ 20.487  Millions$ 5.231  Millions
Intuitive Surgical Inc   3.86 $ 6,475.700  Millions$ 1,676.400  Millions
Tela Bio Inc   3.80 $ 58.202  Millions$ 15.334  Millions
Star Equity Holdings Inc   3.78 $ 25.561  Millions$ 6.761  Millions

Date modified: 2026-09-26T07:39:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.